Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?

The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giuseppe Mameli, Giordano Madeddu, Alessandra Mei, Elena Uleri, Luciana Poddighe, Lucia G Delogu, Ivana Maida, Sergio Babudieri, Caterina Serra, Roberto Manetti, Maria S Mura, Antonina Dolei
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/eb501b17465442e38d579903e5873ff1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb501b17465442e38d579903e5873ff1
record_format dspace
spelling oai:doaj.org-article:eb501b17465442e38d579903e5873ff12021-11-18T08:46:57ZActivation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?1932-620310.1371/journal.pone.0078474https://doaj.org/article/eb501b17465442e38d579903e5873ff12013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24236019/?tool=EBIhttps://doaj.org/toc/1932-6203The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the potentially neuropathogenic HERV-W/MSRV/Syncytin-1 endogenous retroviruses. The ascertained links between EBV and MS are history of late primary infection, possibly leading to infectious mononucleosis (IM), and high titers of pre-onset IgG against EBV nuclear antigens (anti-EBNA IgG). During MS, there is no evidence of MS-specific EBV expression, while a continuous expression of HERV-Ws occurs, paralleling disease behaviour. We found repeatedly extracellular HERV-W/MSRV and MSRV-specific mRNA sequences in MS patients (in blood, spinal fluid, and brain samples), and MRSV presence/load strikingly paralleled MS stages and active/remission phases. Aim of the study was to verify whether HERV-W might be activated in vivo, in hospitalized young adults with IM symptoms, that were analyzed with respect to expression of HERV-W/MSRV transcripts and proteins. Healthy controls were either EBV-negative or latently EBV-infected with/without high titers of anti-EBNA-1 IgG. The results show that activation of HERV-W/MSRV occurs in blood mononuclear cells of IM patients (2Log10 increase of MSRV-type env mRNA accumulation with respect to EBV-negative controls). When healthy controls are stratified for previous EBV infection (high and low, or no anti-EBNA-1 IgG titers), a direct correlation occurs with MSRV mRNA accumulation. Flow cytometry data show increased percentages of cells exposing surface HERV-Wenv protein, that occur differently in specific cell subsets, and in acute disease and past infection. Thus, the data indicate that the two main links between EBV and MS (IM and high anti-EBNA-1-IgG titers) are paralleled by activation of the potentially neuropathogenic HERV-W/MSRV. These novel findings suggest HERV-W/MSRV activation as the missing link between EBV and MS, and may open new avenues of intervention.Giuseppe MameliGiordano MadedduAlessandra MeiElena UleriLuciana PoddigheLucia G DeloguIvana MaidaSergio BabudieriCaterina SerraRoberto ManettiMaria S MuraAntonina DoleiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e78474 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Giuseppe Mameli
Giordano Madeddu
Alessandra Mei
Elena Uleri
Luciana Poddighe
Lucia G Delogu
Ivana Maida
Sergio Babudieri
Caterina Serra
Roberto Manetti
Maria S Mura
Antonina Dolei
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
description The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the potentially neuropathogenic HERV-W/MSRV/Syncytin-1 endogenous retroviruses. The ascertained links between EBV and MS are history of late primary infection, possibly leading to infectious mononucleosis (IM), and high titers of pre-onset IgG against EBV nuclear antigens (anti-EBNA IgG). During MS, there is no evidence of MS-specific EBV expression, while a continuous expression of HERV-Ws occurs, paralleling disease behaviour. We found repeatedly extracellular HERV-W/MSRV and MSRV-specific mRNA sequences in MS patients (in blood, spinal fluid, and brain samples), and MRSV presence/load strikingly paralleled MS stages and active/remission phases. Aim of the study was to verify whether HERV-W might be activated in vivo, in hospitalized young adults with IM symptoms, that were analyzed with respect to expression of HERV-W/MSRV transcripts and proteins. Healthy controls were either EBV-negative or latently EBV-infected with/without high titers of anti-EBNA-1 IgG. The results show that activation of HERV-W/MSRV occurs in blood mononuclear cells of IM patients (2Log10 increase of MSRV-type env mRNA accumulation with respect to EBV-negative controls). When healthy controls are stratified for previous EBV infection (high and low, or no anti-EBNA-1 IgG titers), a direct correlation occurs with MSRV mRNA accumulation. Flow cytometry data show increased percentages of cells exposing surface HERV-Wenv protein, that occur differently in specific cell subsets, and in acute disease and past infection. Thus, the data indicate that the two main links between EBV and MS (IM and high anti-EBNA-1-IgG titers) are paralleled by activation of the potentially neuropathogenic HERV-W/MSRV. These novel findings suggest HERV-W/MSRV activation as the missing link between EBV and MS, and may open new avenues of intervention.
format article
author Giuseppe Mameli
Giordano Madeddu
Alessandra Mei
Elena Uleri
Luciana Poddighe
Lucia G Delogu
Ivana Maida
Sergio Babudieri
Caterina Serra
Roberto Manetti
Maria S Mura
Antonina Dolei
author_facet Giuseppe Mameli
Giordano Madeddu
Alessandra Mei
Elena Uleri
Luciana Poddighe
Lucia G Delogu
Ivana Maida
Sergio Babudieri
Caterina Serra
Roberto Manetti
Maria S Mura
Antonina Dolei
author_sort Giuseppe Mameli
title Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
title_short Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
title_full Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
title_fullStr Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
title_full_unstemmed Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
title_sort activation of msrv-type endogenous retroviruses during infectious mononucleosis and epstein-barr virus latency: the missing link with multiple sclerosis?
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/eb501b17465442e38d579903e5873ff1
work_keys_str_mv AT giuseppemameli activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT giordanomadeddu activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT alessandramei activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT elenauleri activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT lucianapoddighe activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT luciagdelogu activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT ivanamaida activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT sergiobabudieri activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT caterinaserra activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT robertomanetti activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT mariasmura activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
AT antoninadolei activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis
_version_ 1718421357930217472